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Caulfield and Bubela (2007) argue that the Canadian Assisted Human Reproduction Act (An Act Respecting Assisted Human
Reproduction and Related Research (S.C. 2004, c.2) imposes a complete “criminal ban” on somatic cell nuclear transfer
(SCNT) that is unwarranted because, they contend, the ban was based on concerns regarding the moral status of the human
embryo, which is inappropriate in a “pluralistic society.” Based on a close reading of the Act’s provisions, we will suggest
that the Act may not impose a complete “criminal ban” on human SCNT. We will begin, however, by briefly illustrating
that the protection of the health and safety of women, rather than a concern about the moral status of the embryo, is at
the center of the criminal ban on SCNT into the oocytes of women and that the ban is grounded in (what they
acknowledge as) a “lengthy legislative process,” rather than the parliamentary debates privileged in their article.
The Act contains seven guiding principles “that govern the Act and decisions taken under [it]” (Rivard and Hunter
2005, 35), including: the protection of health and safety of Canadians; recognition of the particular position of women in
relation to reproductive technologies; concerns about the commodification of human reproductive material and
processes; and concerns regarding adherence to the principle of informed consent (s.2). Enshrining these principles in
the Act protects women from the harms of undergoing medically unnecessary surgical procedures to remove their
oocytes for SCNT research or any reason other than their reproductive goals (Nisker 2001; Nisker and White 2005). Indeed,
recent examples of the exploitation of women who undergo surgery to provide oocytes for human embryonic stem cell
research, including women working in the laboratories of stem cell researchers in South Korea (Chong 2006; Nisker and
White 2005; Nisker et al. 2006) as well as other socioeconomically disadvantaged women (Nisker and White 2005), are
reasons why “criminal bans” like those in Canada’s Act should exist in all countries where assisted reproduction is
offered. Concerns about the health and safety of women and children, as Caulfield and Bubela (2007) acknowledge, have
been consistently expressed throughout the “lengthy legislative process” that led to the Act.
A careful examination of the Act’s provisions provides no evidence that the moral status of the embryo is of

paramount concern. In fact, the Act does not ban research on human embryos, unlike the legislation in Italy and other
countries referred to by Caulfield and Bubela (2007) where the ban is based on religious views or in Germany and other
countries where non-religious perspectives inform a complete ban on all embryo research. Rather, the Act prohibits the
creation of embryos for research purposes (s.5.(1)(b)), while permitting the research use of embryos donated by
individuals or couples whose embryos were created for their reproductive purposes and are no longer required for that
purpose (Nisker and White 2005). In addition, the Act allows embryos to be discarded or destroyed (s.10.(3)(b)). This
approach to embryo research—just like concerns regarding the health and safety of women and commodification—can
be traced to Canada’s Royal Commission on New Reproductive Technologies (1993) and imbues succeeding expert
panels, advisory committees, white papers, and legislation (Mykitiuk and Wallrap 2002).
Regarding a “criminal ban” on SCNT, we suggest that while the Act clearly prohibits the creation of human clones
(s.5.(1)(a)) and chimeras (s.5.(1)(i)), the Act can be interpreted to permit human SCNT into the oocytes of
nonhuman animals. A “human clone” is defined in the Act as: an embryo that, as a result of the manipulation of human
reproductive material or an in vitro embryo, contains a diploid set of chromosomes obtained from a single—living or deceased—
human being, foetus or embryo (s.3).

“Human reproductive material” is defined under the Act to mean “a sperm, ovum or other human cell or a human
gene, and includes a part of any of them” (s.3). The Act also prohibits the creation of all types of chimeras, defined as:

an embryo into which a cell of any non-human life form has been introduced or b) an embryo that consists of cells of more than
one embryo, foetus or human being (s.3).

Significantly, the legislators chose to include in the Act (s.3) a definition of a hybrid that is defined as:

(a) a human ovum that has been fertilized by a sperm of a nonhuman life form;
(b) an ovum of a non-human life form that has been fertilized by a human sperm;
(c) a human ovum into which the nucleus of a cell of a nonhuman life form has been introduced;
(d) an ovum of a non-human life form into which the nucleus of a human cell has been introduced; or (emphasis added)
(e) a human ovum or an ovum of a non-human life form that otherwise contains haploid sets of chromosomes from both a human
being and a non-human life form.

The Act prohibits the creation of a hybrid “for the purpose of reproduction” and the transfer of a hybrid “into
either a human being or a non-human life form” (s.5.(1)(j)). Therefore not all creations and uses of hybrids are prohibited.
Further, using non-human oocytes as cells into which human somatic nuclear material is transferred creates a hybrid and

not a clone.
Read together, these provisions can be interpreted to mean that while there are “criminal bans” on all creations of
clones (s.5.1(a)) and chimeras (s.5.1(i)), the “criminal ban” on the creation of hybrids relates to their specific uses for
reproduction or transfer, and to specific strategies of creation that are prohibited in other sections of the Act, such as
by SCNT into oocytes purchased from women (s.7.(1)). One might argue that the hybrid form (hybrid d) that we
contend presents the greatest opportunity for SCNT research in Canada (as discussed later in text), could also be a
clone as defined in the Act due to the expanded definition of “human reproductive material” (s.3), which includes
somatic cells. In this definition, materials other than “sperm” and “ovum” could include somatic cells. But, the Act
must be interpreted to achieve consistency and coherence.
We suggest that because the Act legislates specifically with respect to a definition of hybrid, the definition of human
clone provided in the Act is exclusive of those entities that are hybrids. Moreover, “embryo” as defined in the Act, and
referred to in the definition of human clone, “means a human organism. . . and includes any cell derived from such an
organism that is used for the purpose of creating a human being” (s.3). While the Act does not expressly make a distinction
between human embryos and hybrid embryos as is the case in New Zealand’s Human Assisted Reproductive Technology Act
(2004), our view is that, by legislating specifically about hybrids, and permitting their creation but not permitting their
use for reproduction or transfer, the Act draws a distinction between human and hybrid. Further, as a hybrid embryo,
created from human SCNT into a non-human oocyte, has both human (nuclear) and non-human (mitochondrial) DNA,
it is difficult to characterize it as a human embryo.
Although reservations exist regarding the feasibility of SCNT into a non-human oocyte (hybrid d), there is
evidence that this approach may be useful in the report of an embryo created by human SCNT into the oocyte of
a cow (Lanza et al. 1999) and that of a rabbit (Chen et al. 2003). In 2006, several groups of British scientists
submitted applications to the Human Fertilisation and Embryology Authority for permission to pursue this line of
research. As there are relatively few cryopreserved human embryos in Canada that can be donated to stem cell research
(Baylis and Ram 2006; Nisker et al. 2006), unlike Australia and other countries where in vitro fertilization is publicly
funded and large numbers of cryopreserved embryos (no longer required for reproductive purposes) are donated to
research purposes (Nisker et al. 2006), SCNT research using oocytes of non-humans could allow Canadian scientists to
participate in this field of investigation without harming women.
We believe that Canada’s Assisted Human Reproduction Act allows for SCNT research to occur, including that
related to stem cell research, while protecting the health and safety of women in relation to assisted reproductive
technologies, but only in this very limited circumstance. Further, we believe this research must be carried out pursuant
to other restrictions such as those in the Act pertaining to licensing (s.10.(1)) and the destruction of embryos within 14

days (s.5.(1)(d)). We suggest open and broad discussion on the use of oocytes of non-human animals for SCNT research,
and ask Health Canada to conduct public consultations to make sure Canadians want the Act to be interpreted to allow
this strategy.
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